Alzheimer’s drug shows promise in early results of study
Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease’s progress in a late-stage study.
Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease’s progress in a late-stage study.